Like
Share
멍실장
고양이 아밀로이드성 신증 자주 묻는 질문 Q&A — 보호자가 꼭 알아야 할 핵심

Feline Amyloid Nephropathy FAQ — Key Information Every Pet Owner Should Know

UrinaryQ&AMeongsiljang Veterinary Advisory Board

Feline amyloid nephropathy is a degenerative kidney disease with a strong genetic component, and early detection is key to effective treatment. Here’s a summary of the essential information every pet owner should know.

What is feline amyloid nephropathy?

An anatomical image showing amyloid protein deposition within the kidneys
Feline amyloid nephropathy is a kidney disease with a genetic component, in which amyloid proteins gradually accumulate in the glomeruli and interstitium of the kidneys, leading to progressive loss of function. It is most commonly reported in Abyssinian and Siamese cats, which are at higher risk, though cases have been documented in other breeds as well. This condition is classified as a form of non-immune complex glomerulonephritis. When amyloid deposits heavily in the glomeruli, moderate to severe proteinuria occurs; when it primarily accumulates in the interstitium, proteinuria may be minimal or absent. Early stages are often asymptomatic, making early detection very difficult. However, as kidney function declines, serious complications such as anemia, proteinuria, and renal failure can develop. Early diagnosis and ongoing management play a crucial role in slowing disease progression. While there is no cure, early intervention can help delay the advancement of the disease.

What are the main causes of this disease?

The primary cause of feline amyloid nephropathy is genetic predisposition. Familial (hereditary) forms have been reported in Abyssinian cats and are also commonly observed in Siamese cats. This genetic background is linked to the abnormal deposition of amyloid proteins in the kidneys. Amyloid nephropathy is classified as a non-immune complex glomerulonephritis, and the degree of proteinuria can vary depending on the site of deposition. The age of onset varies among individuals, with cases reported in Abyssinians at a relatively young age. For early detection, regular check-ups are essential for cats in genetically at-risk groups.
A diagram illustrating the genetic variants associated with amyloid nephropathy

What are the main symptoms?

Early signs of feline amyloid nephropathy include weight loss, decreased appetite, frequent urination, and excessive urination, with the condition typically progressing silently in most cases. As it advances, symptoms such as vomiting, lethargy, and dehydration (dry lips, reduced skin elasticity) may appear. Severe decline in kidney function can lead to anemia, high blood pressure, and signs of kidney failure. Because early stages often show no obvious signs, careful observation is essential. It’s important to monitor your cat’s daily routine closely so you don’t miss any changes in their behavior or habits.
An image showing lethargy and dehydration, early signs of feline amyloid nephropathy

How is it diagnosed?

Feline amyloid nephropathy is diagnosed through blood tests, urinalysis, renal ultrasound, and tissue biopsy. The condition can be suspected when proteinuria is detected in the urine and blood levels of creatinine and blood urea nitrogen are elevated. Structural changes in the kidneys can be identified via ultrasound, and a definitive diagnosis is made by directly observing amyloid protein deposits through a tissue biopsy. Since test results may appear normal in the early stages, regular check-ups that take the cat’s genetic risk into account are essential. Early detection is the first step toward effective treatment.
A veterinarian performing an ultrasound examination of a cat's kidneys

Comparison of Responses by Symptom Stage

ItemKey signsMain testsManagement direction
Early (asymptomatic)No symptoms, mild proteinuriaUrinalysis, blood testRegular checkups, genetic testing recommended
IntermediateDecreased appetite, polyuria, weight lossRenal ultrasound, consider biopsyDietary management, start medication
AdvancedVomiting, lethargy, dehydrationBlood test, biopsy for definitive diagnosisSupportive care, pain management, hospice care

Early detection greatly determines treatment effectiveness. Cats in genetic risk groups need regular health checkups.

What are the treatment methods?

Treatment for feline amyloid nephropathy focuses on managing symptoms and slowing disease progression rather than removing the amyloid deposits themselves. This involves feeding a specialized renal diet alongside protein restriction. The cornerstone of therapy is using blood pressure medications and agents that reduce protein in the urine to minimize kidney damage. It’s also important to encourage increased water intake and provide a low-stress environment. Early management plays a crucial role in extending life expectancy, so regular veterinary check-ups and monitoring are essential.
Specialized diet for managing feline amyloid nephropathy

Signs Requiring Immediate Veterinary Visit

If your cat suddenly loses its appetite, experiences repeated vomiting, or shows signs of dehydration after excessive urination (such as dry lips and reduced skin elasticity), you should take it to the vet immediately. These are signs of a sudden decline in kidney function, so prompt action is crucial for survival.

Prevention and Management Tips

Because feline amyloid nephropathy has a strong genetic component, complete prevention is difficult, but early detection plays a decisive role in survival. For cats at genetic risk, it is important to consistently monitor kidney function through regular veterinary check-ups. To encourage hydration, offer wet food and place multiple water bowls around the home. Reduce stress by providing a secure, dedicated space for your cat and minimizing changes to their daily routine. Cats at genetic risk should also consider undergoing pre-symptomatic genetic testing.
A water pump and clean water bowl to help encourage your cat’s hydration

Reviewed by a veterinarian

Dr. Tony — Punnawat Phongkittirak

Dr. Tony — Punnawat Phongkittirak

Veterinarian

A veterinarian who majored in veterinary medicine at Khon Kaen University, Thailand, and completed the IVSA program at North Carolina State University in the United States. Drawing on clinical experience at animal hospitals, he works in the pet healthcare field and is dedicated to building a digital care environment that connects pet parents with veterinarians.

Frequently Asked Questions

Do only Abyssinian cats develop amyloidosis?
No. While it is common in Abyssinian and Siamese cats, it can occur in other breeds as well. It is a condition with a strong genetic predisposition.
Is this condition treatable?
While amyloid protein deposits themselves are difficult to remove, disease progression can be slowed and lifespan extended through symptom management and dietary adjustments. Early detection is key.
If my cat has been diagnosed with amyloidosis, is it safe to keep them with other cats?
Yes, it’s not contagious, so it’s safe to keep your cat with other cats. However, because there’s a genetic predisposition, it’s best to avoid breeding.
How should I manage my pet’s diet?
We recommend using a special diet prescribed by your veterinarian. It’s important to control protein and phosphorus intake while increasing water consumption.
How much does this disease reduce a cat's lifespan?
There are no definitive survival statistics for amyloid nephropathy in textbooks, as outcomes vary depending on the individual progression of the disease and the level of care provided. Early detection and appropriate management can help improve both the quality and length of life.

Share

Related Guides

References

[1] Mason, N.J. and Day, M.J. (1996). Renal amyloidosis in related English foxhounds. J. Small Anim. Pract. 37: 255–260.

[2] Boyce, J.T., DiBartola, S.P., Chew, D.J. et al. (1984). Familial renal amyloidosis in Abyssinian cats. Vet. Pathol. 21: 33–38.

[3] de Morais, H.S., DiBartola, S.P., and Chew, D.J. (1996). Juvenile renal disease in golden retrievers: 12 cases (1984–1994). J. Am. Vet. Med. Assoc. 209: 792–797.

This information is based on veterinary literature and does not replace diagnosis or treatment. Please consult a veterinarian for specific health concerns.

Metapet Co., Ltd. | CEO: Park Sung-yong | Business Reg. No. 417-88-02562 | Seoul, South Korea | Customer Center

Feline Amyloid Nephrosis: 5 Frequently Asked Questions and Answers | Meongsiljang